CHALLENGES AND OPPORTUNITIES IN FOG COMPUTING SCHEDULING: A LITERATURE REVIEW





Amrubicin therapy improves patients with refractory small-cell lung cancer: A single-arm confirmatory Chinese clinical study

Our objective was to evaluate an open-label, multicenter, single-arm study to appraise whether amrubicin therapy improves patients with refractory small-cell lung cancer in Chinese clinical study.Patients (n=95) with refractory small-cell lung cancer received 3 consecutive Breathing Support Products days amrubicin therapy for 21 days.Overall respon

read more